Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Medico Remedies Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹40.06 |
52 Week High | ₹92.95 |
52 Week Low | ₹34.80 |
Beta | 0.10 |
1 Month Change | -0.96% |
3 Month Change | -49.71% |
1 Year Change | -55.01% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 65.54% |
Recent News & Updates
Recent updates
Medico Remedies Limited (NSE:MEDICO) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
Mar 22Here's Why We Think Medico Remedies (NSE:MEDICO) Is Well Worth Watching
Jun 22What You Can Learn From Medico Remedies Limited's (NSE:MEDICO) P/E After Its 27% Share Price Crash
Jun 26Estimating The Fair Value Of Medico Remedies Limited (NSE:MEDICO)
Jun 03Shareholder Returns
MEDICO | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 5.4% | 1.7% | 2.7% |
1Y | -55.0% | 53.9% | 44.9% |
Return vs Industry: MEDICO underperformed the Indian Pharmaceuticals industry which returned 53.9% over the past year.
Return vs Market: MEDICO underperformed the Indian Market which returned 44.9% over the past year.
Price Volatility
MEDICO volatility | |
---|---|
MEDICO Average Weekly Movement | 9.1% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.5% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: MEDICO's share price has been volatile over the past 3 months.
Volatility Over Time: MEDICO's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 150 | Harshit Mehta | www.medicoremedies.com |
Medico Remedies Limited manufactures and sells pharmaceutical formulations in India. The company offers antibiotics and anti-infectives; beta-lactams- penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It primarily exports its products.
Medico Remedies Limited Fundamentals Summary
MEDICO fundamental statistics | |
---|---|
Market cap | ₹3.33b |
Earnings (TTM) | ₹82.91m |
Revenue (TTM) | ₹1.45b |
40.2x
P/E Ratio2.3x
P/S RatioIs MEDICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEDICO income statement (TTM) | |
---|---|
Revenue | ₹1.45b |
Cost of Revenue | ₹1.10b |
Gross Profit | ₹350.14m |
Other Expenses | ₹267.23m |
Earnings | ₹82.91m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.00 |
Gross Margin | 24.16% |
Net Profit Margin | 5.72% |
Debt/Equity Ratio | 12.9% |
How did MEDICO perform over the long term?
See historical performance and comparison